annual operating expenses:
$1.69B+$38.01M(+2.31%)Summary
- As of today (September 13, 2025), BMRN annual total operating expenses is $1.69 billion, with the most recent change of +$38.01 million (+2.31%) on December 31, 2024.
- During the last 3 years, BMRN annual operating expenses has risen by +$300.94 million (+21.73%).
- BMRN annual operating expenses is now at all-time high.
Performance
BMRN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$371.03M+$20.90M(+5.97%)Summary
- As of today (September 13, 2025), BMRN quarterly total operating expenses is $371.03 million, with the most recent change of +$20.90 million (+5.97%) on June 30, 2025.
- Over the past year, BMRN quarterly operating expenses has dropped by -$89.41 million (-19.42%).
- BMRN quarterly operating expenses is now -19.42% below its all-time high of $460.44 million, reached on June 30, 2024.
Performance
BMRN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BMRN Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.3% | -19.4% |
| 3 y3 years | +21.7% | +3.6% |
| 5 y5 years | +21.5% | +3.8% |
BMRN Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.7% | -19.4% | +6.0% |
| 5 y | 5-year | at high | +23.9% | -19.4% | +13.4% |
| alltime | all time | at high | >+9999.0% | -19.4% | >+9999.0% |
BMRN Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $371.03M(+6.0%) |
| Mar 2025 | - | $350.13M(-22.9%) |
| Dec 2024 | $1.69B(+2.3%) | $454.31M(+15.1%) |
| Sep 2024 | - | $394.86M(-14.2%) |
| Jun 2024 | - | $460.44M(+6.9%) |
| Mar 2024 | - | $430.89M(-2.4%) |
| Dec 2023 | $1.65B(+10.5%) | $441.52M(+4.5%) |
| Sep 2023 | - | $422.71M(+7.2%) |
| Jun 2023 | - | $394.14M(+1.0%) |
| Mar 2023 | - | $390.23M(-2.4%) |
| Dec 2022 | $1.49B(+7.6%) | $400.00M(+6.0%) |
| Sep 2022 | - | $377.28M(+5.3%) |
| Jun 2022 | - | $358.18M(+0.8%) |
| Mar 2022 | - | $355.37M(-5.9%) |
| Dec 2021 | $1.38B(+1.8%) | $377.85M(+10.7%) |
| Sep 2021 | - | $341.20M(-0.3%) |
| Jun 2021 | - | $342.35M(+4.6%) |
| Mar 2021 | - | $327.32M(-4.2%) |
| Dec 2020 | $1.36B(-1.9%) | $341.80M(+3.6%) |
| Sep 2020 | - | $329.85M(-7.7%) |
| Jun 2020 | - | $357.49M(+7.8%) |
| Mar 2020 | - | $331.69M(-7.6%) |
| Dec 2019 | $1.39B(+5.9%) | $359.07M(+5.5%) |
| Sep 2019 | - | $340.40M(-1.2%) |
| Jun 2019 | - | $344.71M(+0.5%) |
| Mar 2019 | - | $343.04M(-0.3%) |
| Dec 2018 | $1.31B(+11.4%) | $344.24M(+10.0%) |
| Sep 2018 | - | $313.08M(-4.8%) |
| Jun 2018 | - | $328.73M(+1.1%) |
| Mar 2018 | - | $325.02M(-1.7%) |
| Dec 2017 | $1.18B(+3.3%) | $330.81M(+14.9%) |
| Sep 2017 | - | $287.92M(-1.5%) |
| Jun 2017 | - | $292.32M(+10.3%) |
| Mar 2017 | - | $265.13M(-16.7%) |
| Dec 2016 | $1.14B(+10.3%) | $318.20M(+13.5%) |
| Sep 2016 | - | $280.47M(+1.4%) |
| Jun 2016 | - | $276.62M(+2.1%) |
| Mar 2016 | - | $270.93M(-6.6%) |
| Dec 2015 | $1.03B(+32.3%) | $290.02M(+14.7%) |
| Sep 2015 | - | $252.75M(-2.2%) |
| Jun 2015 | - | $258.55M(+9.6%) |
| Mar 2015 | - | $235.82M(-2.5%) |
| Dec 2014 | $779.91M(+32.6%) | $241.84M(+18.3%) |
| Sep 2014 | - | $204.48M(+15.9%) |
| Jun 2014 | - | $176.43M(+14.0%) |
| Mar 2014 | - | $154.77M(-2.7%) |
| Dec 2013 | $588.10M(+17.7%) | $159.01M(+14.2%) |
| Sep 2013 | - | $139.27M(+10.2%) |
| Jun 2013 | - | $126.34M(-0.5%) |
| Mar 2013 | - | $126.99M(-2.9%) |
| Dec 2012 | $499.72M(+39.4%) | $130.82M(+15.0%) |
| Sep 2012 | - | $113.74M(-13.4%) |
| Jun 2012 | - | $131.32M(+10.6%) |
| Mar 2012 | - | $118.70M(+53.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $358.57M(+19.9%) | $77.48M(-15.7%) |
| Sep 2011 | - | $91.92M(-1.0%) |
| Jun 2011 | - | $92.82M(+10.2%) |
| Mar 2011 | - | $84.25M(-0.1%) |
| Dec 2010 | $299.03M(+24.9%) | $84.30M(+7.6%) |
| Sep 2010 | - | $78.31M(+3.1%) |
| Jun 2010 | - | $75.97M(+12.5%) |
| Mar 2010 | - | $67.54M(-10.2%) |
| Dec 2009 | $239.41M(+19.8%) | $75.21M(+13.1%) |
| Sep 2009 | - | $66.52M(+17.0%) |
| Jun 2009 | - | $56.85M(-9.9%) |
| Mar 2009 | - | $63.13M(+15.9%) |
| Dec 2008 | $199.86M(+28.0%) | $54.46M(-1.2%) |
| Sep 2008 | - | $55.14M(+12.6%) |
| Jun 2008 | - | $48.96M(+18.6%) |
| Mar 2008 | - | $41.30M(-13.8%) |
| Dec 2007 | $156.14M(+45.3%) | $47.91M(+29.6%) |
| Sep 2007 | - | $36.95M(+0.3%) |
| Jun 2007 | - | $36.84M(+6.9%) |
| Mar 2007 | - | $34.44M(+4.1%) |
| Dec 2006 | $107.46M(+20.7%) | $33.08M(+22.7%) |
| Sep 2006 | - | $26.96M(+2.4%) |
| Jun 2006 | - | $26.34M(+25.3%) |
| Mar 2006 | - | $21.01M(-6.2%) |
| Dec 2005 | $89.02M(+14.0%) | $22.41M(+5.1%) |
| Sep 2005 | - | $21.33M(-7.7%) |
| Jun 2005 | - | $23.11M(-2.4%) |
| Mar 2005 | - | $23.66M(-10.0%) |
| Dec 2004 | $78.10M(+30.7%) | $26.29M(+53.3%) |
| Sep 2004 | - | $17.15M(-0.6%) |
| Jun 2004 | - | $17.25M(-1.9%) |
| Mar 2004 | - | $17.58M(-30.0%) |
| Dec 2003 | $59.77M(-0.5%) | $25.11M(+41.6%) |
| Sep 2003 | - | $17.74M(+9.6%) |
| Jun 2003 | - | $16.19M(-21.2%) |
| Mar 2003 | - | $20.54M(+26.9%) |
| Dec 2002 | $60.09M(+31.1%) | $16.19M(-1.1%) |
| Sep 2002 | - | $16.38M(+13.5%) |
| Jun 2002 | - | $14.43M(-5.6%) |
| Mar 2002 | - | $15.29M(+37.2%) |
| Dec 2001 | $45.83M(+18.5%) | - |
| Sep 2001 | - | $11.14M(-4.3%) |
| Jun 2001 | - | $11.64M(+3.1%) |
| Mar 2001 | - | $11.30M(-3890.6%) |
| Dec 2000 | $38.66M(+34.3%) | -$298.00K(-102.6%) |
| Sep 2000 | - | $11.44M(+30.2%) |
| Jun 2000 | - | $8.78M(-4.5%) |
| Mar 2000 | - | $9.19M(+85.8%) |
| Dec 1999 | $28.79M(+114.0%) | $4.95M(-49.5%) |
| Sep 1999 | - | $9.81M(+31.5%) |
| Jun 1999 | - | $7.46M(+52.4%) |
| Mar 1999 | - | $4.89M |
| Dec 1998 | $13.45M(+376.6%) | - |
| Dec 1997 | $2.82M | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual total operating expenses?
- What is the all time high annual operating expenses for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual operating expenses year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly operating expenses year-on-year change?
What is BioMarin Pharmaceutical Inc. annual total operating expenses?
The current annual operating expenses of BMRN is $1.69B
What is the all time high annual operating expenses for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual total operating expenses is $1.69B
What is BioMarin Pharmaceutical Inc. annual operating expenses year-on-year change?
Over the past year, BMRN annual total operating expenses has changed by +$38.01M (+2.31%)
What is BioMarin Pharmaceutical Inc. quarterly total operating expenses?
The current quarterly operating expenses of BMRN is $371.03M
What is the all time high quarterly operating expenses for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly total operating expenses is $460.44M
What is BioMarin Pharmaceutical Inc. quarterly operating expenses year-on-year change?
Over the past year, BMRN quarterly total operating expenses has changed by -$89.41M (-19.42%)